Global Stem Cell Group subsidiary Stem Cell Training, Inc. has announced the release of its new online accredited stem cell training course that can be completed from the home or office.
GlobalStemCellsGroup.com, its subsidiary Stem Cell Training, Inc. and Bioheart, Inc. have announced a new 16 CME online credit course for physicians. Working at their own pace from the privacy of home or office, physicians can learn how to implement regenerative medicine techniques in their own practices.
Taught by stem cell and regenerative medicine expert Kristin Comella, the online course provides didactic lectures on regenerative medicine and scientifically validated protocols. Lecture topics include:
Stem cell biology
Induced pluripotent stem cells
cGMPs for stem cell therapies
Embryonic stem cells
Bone Marrow stem cells
Adipose derived stem cells
Harvesting and isolation of adipose derived stem cells
Harvesting and isolation of bone marrow stem cells
Included in the online coursework are training videos, training booklets, detailed protocols and power point presentations with instructions and images for:
Adipose stem cell isolation
Bone marrow stem cell isolation
Platelet rich plasma
Patient forms and guidelines (including editable and non-editable confidential medical history for pre- and post-medical instruction, safety guidelines for harvesting adipose tissue, blood work request flyer and confirmation of treatment detailer)
Sample informed consent forms (for adipose derived stem cells, bone marrow derived stem cells and platelet-rich plasma)
Stem Cell Banking with flyers for physicians and patients, as well as stem cell banking requests for cryopreservation
Stem cell training lecture notes
Access to regenerative medicine experts
Medical professionals can also choose to combine the online coursework with one-on-one training with a regenerative medicine specialist.
For more information, visit the Global Stem Cells website,, email bnovas(at)stemcellsgroup(dot)com, or call 305-560-5337.
About Kristin Comella:
Kristin Comella has more than 15 years’ experience in corporate entities with expertise in regenerative medicine. Comella has pioneered a variety of stem cell therapies including cord blood derived cells, bone marrow cells, muscle cells and adipose cells for use in many different applications. As Chief Scientific Officer for Bioheart, Inc., Comella has developed a wide range of regenerative products and techniques that have been successfully implemented into the clinic, and has led her team to earn the first ever FDA approval for clinical trials using a combined cell and gene therapy product.
Bioheart is a publicly traded company focusing on the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases. Since joining Bioheart in 2004, Comella has played a major role in managing the product development, manufacturing and quality systems of cellular products. Comella currently and actively serves on multiple boards in the stem cell arena. She joined forces with Global Stem Cells Group and its subsidiary Stem Cells Training in 2013 to design and lead intensive, hands-on stem cell training courses to industry professionals in the U.S. and abroad.